122 related articles for article (PubMed ID: 18767947)
21. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
22. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
23. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
24. The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.
Li G; Mitra S; Wong AJ
Neurosurg Clin N Am; 2010 Jan; 21(1):87-93. PubMed ID: 19944969
[TBL] [Abstract][Full Text] [Related]
25. Strategies used for MUC1 immunotherapy: preclinical studies.
Tang CK; Apostolopoulos V
Expert Rev Vaccines; 2008 Sep; 7(7):951-62. PubMed ID: 18767945
[TBL] [Abstract][Full Text] [Related]
26. EGF receptors as a target for cancer therapy.
Mendelsohn J
Trans Am Clin Climatol Assoc; 2004; 115():249-53; discussion 253-4. PubMed ID: 17060971
[No Abstract] [Full Text] [Related]
27. Epidermal growth factor receptor and variant III targeted immunotherapy.
Congdon KL; Gedeon PC; Suryadevara CM; Caruso HG; Cooper LJ; Heimberger AB; Sampson JH
Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii20-5. PubMed ID: 25342601
[TBL] [Abstract][Full Text] [Related]
28. Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers.
Simon N; FitzGerald D
Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153091
[TBL] [Abstract][Full Text] [Related]
29. A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition.
Wollenberg A; Moosmann N; Klein E; Katzer K
Exp Dermatol; 2008 Sep; 17(9):790-2. PubMed ID: 18503553
[TBL] [Abstract][Full Text] [Related]
30. ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.
Gatson NT; Weathers SP; de Groot JF
CNS Oncol; 2016; 5(1):11-26. PubMed ID: 26670466
[TBL] [Abstract][Full Text] [Related]
31. A six-foot lab rat.
Underwood A
Newsweek; 2006 Dec; 148(24):69-70, 73. PubMed ID: 17186889
[No Abstract] [Full Text] [Related]
32. [Recent developments in cancer research].
Mathe G
Maroc Med; 1972 Oct; 52(561):539-41. PubMed ID: 4667464
[No Abstract] [Full Text] [Related]
33. Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease.
Kurzrock R; Kato S
Oncology (Williston Park); 2018 Apr; 32(4):150-1, 163. PubMed ID: 29684227
[No Abstract] [Full Text] [Related]
34. Tumour immunotherapy register.
Nurs Mirror Midwives J; 1974 Jul; 139(4):50. PubMed ID: 4496104
[No Abstract] [Full Text] [Related]
35. The role of immunological factors in viral and oncogenic processes. Introduction.
Beers RF
Johns Hopkins Med J Suppl; 1974; 3():xxi-xxii. PubMed ID: 4423932
[No Abstract] [Full Text] [Related]
36. Immunotherapy of human cancers.
Hobbs JR
BMJ; 1989 Nov; 299(6709):1177-8. PubMed ID: 2513045
[No Abstract] [Full Text] [Related]
37. The past, present and future of multi-targeted cancer treatment "naturally": food for thought.
Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):187-8. PubMed ID: 18504071
[No Abstract] [Full Text] [Related]
38. What is the relevance of determining EGFR-variant-III status in glioblastomas?
Omuro AM
Nat Clin Pract Oncol; 2008 Apr; 5(4):188-9. PubMed ID: 18319741
[No Abstract] [Full Text] [Related]
39. Cancer prevention vaccine.
Hadley HG
Taiwan Yi Xue Hui Za Zhi; 1969 Nov; 68(11):563. PubMed ID: 5266441
[No Abstract] [Full Text] [Related]
40. Cancer matters: Now more than ever!
Ramalingam SS
Cancer; 2021 Jul; 127(13):2174-2176. PubMed ID: 34115888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
